Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by smush74on Oct 13, 2016 5:56pm

126 Views

Post# 25341437

RE:Does a EDT holder need to know about BioMs, SDI or other

when BioMS phase III trial failed they had close to 90 million in the bank from milestone payment from Lilly. After they became Medwell capital and were delisted from TSX to Venture as they were no longer a biotech and no longer fit the criterea.

With that money they bought into Specrtal and later divested millions of their shares to its holders.

Other than I believe a board seat and K. Giesse still holds a few million shares there is no comparison or need for concern.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario